Showing 1 - 14 results of 14 for search 'S. Madouri', query time: 0.03s
Refine Results
-
1
Fintech, financial inclusion, and sustainable development in the African region by Chemseddine Tidjani, Abderazak Madouri
Published 2024-04-01
Article -
2
Incidence of clozapine-induced hematological side effects in a Tunisian population by M. Shiri, A. Ouertani, S. Madouri, U. Ouali
Published 2022-06-01
Article -
3
antipsychotics and metabolic syndrome by R. Jomli, H. Jemli, U. Ouali, A. Ouertani, S. Madouri
Published 2022-06-01
Article -
4
Schizophrenia and Multiple Sclerosis: Common pathways, common risk-factors by H. Jemli, U. Ouali, S. Madouri, A. Aissa, R. Jomli
Published 2022-06-01
Article -
5
Somnambulism induced by Hydroxyzine by R. Jomli, H. Jemli, H. Ghabi, S. Madouri, A. Ouertani, U. Ouali
Published 2022-06-01
Article -
6
-
7
Clozapine cessation by H. Ktari, A. Ouertani, S. Madouri, A. Aissa, Y. Zgueb, U. Ouali, R. Jomli
Published 2022-06-01
Article -
8
Epidemiological and clinical profile of suicide attempts in Tunisian adolescents by R. Boukhchina, A. Aissa, I. Kammoun, Y. Zgueb, S. Madouri, U. Ouali, R. Jomli
Published 2022-06-01
Article -
9
Particularities of suicide attempts in late adolescence in Tunisia by R. Boukhchina, A. Aissa, I. Kammoun, Y. Zgueb, S. Madouri, U. Ouali, R. Jomli
Published 2022-06-01
Article -
10
Time of onset of hematological side effects with Clozapine by H. Ktari, A. Ouertani, S. Madouri, A. Aissa, Y. Zgueb, U. Ouali, R. Jomli
Published 2022-06-01
Article -
11
IL-20 Cytokines Are Involved in the Repair of Airway Epithelial Barrier: Implication in Exposure to Cigarette Smoke and in COPD Pathology by Olivia Barada, Sophie Salomé-Desnoulez, Fahima Madouri, Gaëtan Deslée, Christelle Coraux, Philippe Gosset, Muriel Pichavant
Published 2023-10-01
Article -
12
“I have brain fog…” About cognitive impairment after COVID-19 by H. Ghabi, A. Aissa, A. Zili, A. Ben Cheikh Ahmed, Y. Zgueb, S. Madouri, U. Ouali, R. Jomli
Published 2022-06-01
Article -
13
T Lymphocyte Serotonin 5-HT<sub>7</sub> Receptor Is Dysregulated in Natalizumab-Treated Multiple Sclerosis Patients by Flora Reverchon, Colleen Guillard, Lucile Mollet, Pascal Auzou, David Gosset, Fahima Madouri, Antoine Valéry, Arnaud Menuet, Canan Ozsancak, Maud Pallix-Guyot, Séverine Morisset-Lopez
Published 2022-09-01
Article -
14
Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis by Bénédicte Oxombre, Fahima Madouri, Anne-Sophie Journé, Séverine Ravez, Eloise Woitrain, Pascal Odou, Nathalie Duhal, Sandro Ninni, David Montaigne, Nadira Delhem, Patrick Vermersch, Patricia Melnyk
Published 2022-10-01
Article